Wolf Hill Capital Management LP Takes $47.41 Million Position in Teleflex Incorporated $TFX

Wolf Hill Capital Management LP bought a new stake in Teleflex Incorporated (NYSE:TFX) in the fourth quarter, Holdings Channel.com reports. The firm bought 388,440 shares of the medical technology company’s stock, valued at approximately $47,405,000. Teleflex makes up about 5.2% of Wolf Hill Capital Management LP’s holdings, making the stock its 7th biggest position.

Other hedge funds have also modified their holdings of the company. Banque Cantonale Vaudoise raised its position in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after buying an additional 113 shares during the last quarter. V Square Quantitative Management LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at about $37,000. UMB Bank n.a. raised its position in shares of Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after buying an additional 113 shares during the last quarter. Sound Income Strategies LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at about $45,000. Finally, Kestra Advisory Services LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at about $45,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Down 0.2%

Shares of TFX opened at $130.24 on Monday. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $139.67. The firm has a 50-day moving average price of $128.67 and a 200 day moving average price of $118.98. The firm has a market capitalization of $5.77 billion, a P/E ratio of -5.71, a P/E/G ratio of 0.97 and a beta of 0.82.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. During the same quarter in the prior year, the firm posted $1.44 earnings per share. Teleflex’s quarterly revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is -5.96%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on TFX shares. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research report on Friday, March 27th. Mizuho set a $140.00 price objective on shares of Teleflex in a report on Friday, May 8th. Needham & Company LLC upped their price objective on shares of Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Wall Street Zen lowered shares of Teleflex from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Four investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $146.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.